• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Radiologic Imaging  • Renal Diseases  • Dialysis  • Renal Diseases, Other  • Magnetic Resonance Imaging  • Dermatologic Procedures  • Phototherapy  • Alert me on articles by topic  Social Bookmarking   What's this?

Alexander Kreuter, MD; Thilo Gambichler, MD; Stefan M. Weiner, MD; Gisela Schieren, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Nephrogenic systemic fibrosis (NSF) is an emerging sclerodermalike disease that affects almost exclusively patients undergoing hemodialysis for end-stage renal disease (ESRD). Increasing evidence indicates that NSF is induced by gadolinium-based contrast agents commonly used in magnetic resonance imaging (MRI). Nephrogenic systemic fibrosis may result in significant morbidity and mortality, and a high proportion of patients end up in wheelchairs or become bedridden because of their progressive joint contractures. To date, no consistently effective therapy is available for NSF. Phototherapy with UV-A1, frequently used for other sclerotic skin diseases, has been reported to have beneficial effects in NSF.¹ We herein report our results from 3 patients treated with UV-A1 phototherapy (Table).

Table appears in full text version. Table. Clinical Characteristics and Responses to UV-A1 Phototherapy

Report of a Case

A 50-year-old man presented with a rapid onset of diffusely thickened hyperpigmented skin affecting all 4 extremities. . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nephrogenic Systemic Fibrosis: Review of 370 Biopsy-Confirmed Cases
Zou et al.
J Am Coll Cardiol Img 2011;4:1206-1216.
ABSTRACT | FULL TEXT  

Detection of Clonal T Cells in the Circulation of Patients With Nephrogenic Systemic Fibrosis
Kreuter et al.
Arch Dermatol 2009;145:1164-1169.
ABSTRACT | FULL TEXT  

Estimates of Risk, Empirical Treatment Observations, and Unexpected Laboratory Findings Reveal the Complexity of Nephrogenic Systemic Fibrosis
High
Arch Dermatol 2009;145:1178-1182.
FULL TEXT